Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGXT | P21549 | 1/20 | 0.46 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.42 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.42 |
| ▸ | ASIC3 | Q9UHC3 | 1/20 | 0.42 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.42 |
| ▸ | ADRA1D | P25100 | 2/20 | 0.36 |
| ▸ | CASR | P41180 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | GLS | O94925 | 2/20 | 0.33 |
| ▸ | IDH1 | O75874 | 1/20 | 0.33 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.33 |
| ▸ | MGLL | Q99685 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4607947 | 0.70 | BACE1 (0.32) | — | |
| SCHEMBL8664580 | 0.70 | HRH3 (0.35) | — | |
| SCHEMBL662224 | 0.69 | AGXT (0.43) | AGXTCYP2A6ADRB2ASIC3LOXL2 | |
| SCHEMBL2168948 | 0.69 | — | — | |
| SCHEMBL1246811 | 0.68 | PRKCI (0.33) | — | |
| SCHEMBL660879 | 0.68 | AGXT (0.42) | AGXTCYP2A6ADRB2ASIC3LOXL2 | |
| SCHEMBL6844411 | 0.68 | AGXT (0.42) | AGXTCYP2A6ADRB2ASIC3LOXL2 | |
| SCHEMBL660878 | 0.68 | AGXT (0.42) | AGXTCYP2A6ADRB2ASIC3LOXL2 | |
| SCHEMBL274427 | 0.67 | CYP2A6 (0.58) | AGXTCYP2A6ADRB2ASIC3LOXL2 | |
| SCHEMBL347531 | 0.67 | CYP2A6 (0.58) | AGXTCYP2A6ADRB2ASIC3LOXL2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1812387-A1 | 2,3,4-SUBSTITUTED CYCLOPENTANONES AS THERAPEUTIC AGENTS | Allergan, Inc. (US) | 2007-08-01 | — | — | EP | disclosed |
| WO-2006055481-A1 | 2,3,4-SUBSTITUTED CYCLOPENTANONES AS THERAPEUTIC AGENTS | ALLERGAN , INC. (US) | 2006-05-26 | — | — | WO | disclosed |